Computer-guided concentration-controlled trials in autoimmune disorders

John McMichael, R. Lieberman, H. Doyle, J. McCauley, D. Van Thiel, A. Thomson, J. Fung, T. E. Starzl

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

A randomized concentration-controlled clinical trial (RCCCT) is an alternate experimental design to the standard dose-controlled study. In a RCCCT, patients are randomly assigned to predefined plasma or blood drug concentration ranges (low, medium, and high). With the caveat that concentration ranges are sufficiently separated, this design should enhance the ability to discover important concentration response relationships. FK-506, a potent and promising immunosuppressive agent for prevention and treatment of graft rejection, has shown significant clinical activity in some immune-mediated disorders. To implement the RCCCT design, a novel FK-506 intelligent dosing system (IDS) was used to guide all doses to prospectively achieve the target concentration range specified in the study protocol. Patients enrolled in these trials suffered from a variety of autoimmune disorders, including multiple sclerosis, primary biliary cirrhosis, psoriasis, autoimmune chronic active hepatitis, and nephrotic syndrome. We observed excellent predictive performance of the IDS for all patients. The accuracy (mean prediction error) of the IDS was −0.022 ng/ml and the precision (standard deviation of the prediction error) was 0.119 ng/ml. Thus, the IDS is both accurate and reproducible for autoimmune patients. We conclude that the RCCCT design, guided by an accurate and precise IDS, is an informative and cost-effective approach for evaluation of efficacy and safety of effective but highly toxic agents.

Original languageEnglish (US)
Pages (from-to)510-513
Number of pages4
JournalTherapeutic Drug Monitoring
Volume15
Issue number6
DOIs
StatePublished - Dec 1993

Keywords

  • Autoimmune diseases
  • Concentration-controlled artificial intelligence
  • Dynamic dosing

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Computer-guided concentration-controlled trials in autoimmune disorders'. Together they form a unique fingerprint.

  • Cite this

    McMichael, J., Lieberman, R., Doyle, H., McCauley, J., Van Thiel, D., Thomson, A., Fung, J., & Starzl, T. E. (1993). Computer-guided concentration-controlled trials in autoimmune disorders. Therapeutic Drug Monitoring, 15(6), 510-513. https://doi.org/10.1097/00007691-199312000-00010